FisherVista

FisherVista

@fishervista

28998 articles
Sales Nexus CRM

Articles

Auddia Files S-4 for Merger with Thramann Holdings, Creating McCarthy Finney AI Platform

Auddia Files S-4 for Merger with Thramann Holdings, Creating McCarthy Finney AI Platform

Auddia Inc. filed a registration statement with the SEC to merge with Thramann Holdings, forming McCarthy Finney, a unified AI holding company operating four AI-enabled businesses on a shared operating system.
KeyCrew Media Names Daryl Judy as Verified Expert in DC Luxury Real Estate

KeyCrew Media Names Daryl Judy as Verified Expert in DC Luxury Real Estate

KeyCrew Media selects top DC luxury real estate agent Daryl Judy as a Verified Expert to provide exclusive market intelligence on the DMV luxury market, highlighting fast-moving trends and off-market transactions.
BioStem Technologies Posts $6.1M Q1 Revenue, Advances Nasdaq Uplisting After Strategic Transformation

BioStem Technologies Posts $6.1M Q1 Revenue, Advances Nasdaq Uplisting After Strategic Transformation

BioStem Technologies reported first quarter 2026 net revenue of $6.1 million, a shift toward hospital market focus following the BioTissue assets acquisition, and progress toward a planned Nasdaq uplisting.
GeoVax Reports First Quarter 2026 Financial Results and Advances GEO-MVA Phase 3 Trial for Mpox Vaccine

GeoVax Reports First Quarter 2026 Financial Results and Advances GEO-MVA Phase 3 Trial for Mpox Vaccine

GeoVax Labs reported a net loss of $5.3 million for Q1 2026 and provided updates on its GEO-MVA mpox/smallpox vaccine, which is advancing toward a Phase 3 immunobridging study under an EMA-aligned expedited pathway, addressing global supply constraints and biodefense priorities.
Aemetis 1Q26 Results Show Progress Toward Low-Carbon Fuel Monetization

Aemetis 1Q26 Results Show Progress Toward Low-Carbon Fuel Monetization

Aemetis reported improved financials in 1Q26, with revenue up 27% and gross profit turning positive, driven by recurring 45Z credit recognition and expanding RNG volumes.
HeartBeam Advances Commercial Launch, Reports First-Quarter 2026 Results

HeartBeam Advances Commercial Launch, Reports First-Quarter 2026 Results

HeartBeam reported first-quarter 2026 results highlighting the launch of commercial partnerships and progress in heart attack detection initiatives, with a reduced net loss of $4.7 million.
BOXABL and FG Merger II Advance Toward Public Listing as SEC Clears S-4 Registration

BOXABL and FG Merger II Advance Toward Public Listing as SEC Clears S-4 Registration

BOXABL and FG Merger II Corp. announced SEC effectiveness of their S-4 registration, setting shareholder meetings for June 9, 2026, to approve the business combination that would take BOXABL public on Nasdaq under ticker BXBL.
Carmed Pharmaceuticals Expands U.S. Presence with Launch on OneLavi.com

Carmed Pharmaceuticals Expands U.S. Presence with Launch on OneLavi.com

Carmed Pharmaceuticals, a Turkey-based company, launches select carvacrol-based formulations on OneLavi.com, marking a key step in its U.S. expansion strategy through curated wellness platforms.
Comedy Village Brings Live Stand-Up Comedy to 51st Annual Ninth Avenue International Food Festival

Comedy Village Brings Live Stand-Up Comedy to 51st Annual Ninth Avenue International Food Festival

Comedy Village will host a live stand-up comedy showcase on May 17, 2026, at the 51st Annual Ninth Avenue International Food Festival in Times Square and Hell’s Kitchen, featuring nationally recognized comedians.
Dogwood Therapeutics Reports First Quarter 2026 Results, Advances Pain Pipeline with Halneuron and SP16

Dogwood Therapeutics Reports First Quarter 2026 Results, Advances Pain Pipeline with Halneuron and SP16

Dogwood Therapeutics announced Q1 2026 financial results and highlighted progress in its non-opioid pain pipeline, including Phase 2b data for Halneuron expected in fall 2026 and FDA clearance for SP16 to enter Phase 1b.
AI SEO Autopilot Launches With 99% Automation, Targeting LLM Visibility

AI SEO Autopilot Launches With 99% Automation, Targeting LLM Visibility

Cinderix releases AI SEO Autopilot, an autonomous system powered by OTTO SEO agents that automates 99% of SEO tasks and optimizes for AI-driven discovery tools like ChatGPT and Gemini.
Ontario Engineer Launches Consulting Practice to Build Custom Internal Tools for Fintech and SaaS Teams

Ontario Engineer Launches Consulting Practice to Build Custom Internal Tools for Fintech and SaaS Teams

Franz Wiebe, a product engineer based in Aylmer, Ontario, has launched a consulting practice offering custom internal tools and SaaS MVP development, aiming to replace fragmented software stacks with cohesive, custom-built systems.
Keona Health's Rule of ONE Framework Targets Fragmented Healthcare Call Center Workflows

Keona Health's Rule of ONE Framework Targets Fragmented Healthcare Call Center Workflows

Keona Health's analysis introduces the Rule of ONE framework to standardize healthcare call center operations, aiming to reduce inefficiencies caused by fragmented systems and inconsistent processes.
LIG Assets Advances SK-1300 Valuation for Marianna Calcium Mine, Citing Significant Value Increase Since 2009

LIG Assets Advances SK-1300 Valuation for Marianna Calcium Mine, Citing Significant Value Increase Since 2009

LIG Assets, Inc. is working on a technical report under SEC Regulation S-K Subpart 1300 to update the valuation of its calcium carbonate mining assets in Marianna, Florida, which were previously appraised at $400 million in 2009, aiming to reflect substantial market changes and enhance transparency.
HR.com Honors 2026 Winners for HR Tech Innovation and Implementation

HR.com Honors 2026 Winners for HR Tech Innovation and Implementation

HR.com has announced the winners of the 2026 HR Tech Innovation & Implementation Awards, recognizing Harbinger Group and Willow Bridge Property Company for their transformative HR technology solutions.
SureNano Science’s GLP-1 Triple Agonist GEP-44 Could Reshape Obesity and Diabetes Treatment

SureNano Science’s GLP-1 Triple Agonist GEP-44 Could Reshape Obesity and Diabetes Treatment

SureNano Science Ltd. announced its featured BioMedWire editorial on GEP-44, a novel triple agonist peptide from its subsidiary GlucaPharm Inc., aiming to improve efficacy, tolerability, and delivery flexibility in obesity and type 2 diabetes care.
BluSky AI Launches Regulation A+ Offering to Expand AI Infrastructure Network

BluSky AI Launches Regulation A+ Offering to Expand AI Infrastructure Network

BluSky AI Inc. announced a Regulation A+ offering to raise funds for expanding its modular AI Factory footprint and Neocloud compute capacity across the United States, allowing individual and accredited investors to participate with a minimum investment of $1,000.
American Fusion Engages Washington D.C. on Defense and Energy Applications, Advances Commercialization

American Fusion Engages Washington D.C. on Defense and Energy Applications, Advances Commercialization

American Fusion Inc. updates on strategic D.C. engagements for its Texatron Fusion Engine in defense and energy, while progressing toward OTCQB listing and 5MW pre-production unit.
NextPlat Corp Reports Improved Q1 Results, Nears Profitability Targets

NextPlat Corp Reports Improved Q1 Results, Nears Profitability Targets

NextPlat Corp posts record gross margins and reduced losses in Q1 2026 as turnaround efforts gain traction, targeting positive operating income by H2.
Aditxt Announces 1-for-27 Reverse Stock Split to Regain Nasdaq Compliance

Aditxt Announces 1-for-27 Reverse Stock Split to Regain Nasdaq Compliance

Aditxt (NASDAQ: ADTX) will implement a 1-for-27 reverse stock split on May 18, 2026, to meet Nasdaq’s minimum bid price requirement, reducing outstanding shares from 13.8 million to about 510,123.
Oncotelic Therapeutics Featured in BioMedWire Editorial Highlighting Nose-to-Brain Drug Delivery for Alzheimer's and Biodefense

Oncotelic Therapeutics Featured in BioMedWire Editorial Highlighting Nose-to-Brain Drug Delivery for Alzheimer's and Biodefense

Oncotelic Therapeutics' intranasal delivery platform that bypasses the blood-brain barrier is featured in a BioMedWire editorial, underscoring its potential impact on neurological treatments and biodefense.

Showing 6217-6237 of 28998 articles (Page 297 of 1381)